Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by UniSuper Management Pty Ltd

UniSuper Management Pty Ltd grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,354 shares of the medical equipment provider's stock after acquiring an additional 4,793 shares during the quarter. UniSuper Management Pty Ltd's holdings in Intuitive Surgical were worth $30,980,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in ISRG. Sava Infond d.o.o. purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $4,979,000. WINTON GROUP Ltd purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $1,021,000. Artisan Partners Limited Partnership boosted its stake in Intuitive Surgical by 8.8% in the fourth quarter. Artisan Partners Limited Partnership now owns 156,551 shares of the medical equipment provider's stock valued at $81,713,000 after acquiring an additional 12,660 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Intuitive Surgical by 6.1% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 704,935 shares of the medical equipment provider's stock worth $377,348,000 after purchasing an additional 40,649 shares in the last quarter. Finally, Ausdal Financial Partners Inc. lifted its holdings in shares of Intuitive Surgical by 3.0% during the 4th quarter. Ausdal Financial Partners Inc. now owns 1,977 shares of the medical equipment provider's stock valued at $1,032,000 after purchasing an additional 57 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insider Activity

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several brokerages recently issued reports on ISRG. CICC Research started coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 target price on the stock. Piper Sandler reaffirmed an "overweight" rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. UBS Group boosted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Truist Financial cut their target price on Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating on the stock in a research report on Monday, March 17th. Finally, Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $611.86.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $16.06 during trading hours on Friday, reaching $491.84. The company's stock had a trading volume of 1,966,546 shares, compared to its average volume of 1,527,047. The firm has a market capitalization of $175.18 billion, a price-to-earnings ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43. The company's 50-day moving average is $556.28 and its two-hundred day moving average is $532.68. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.